Clinical Trial Update: Targeting the Hippo Transducer TAZ in Breast Cancer With Statins [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether statins can modulate the Hippo pathway transducer TAZ to treat breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Statin class (statin)

Snippet

Sponsor: Regina Elena Cancer Institute | Conditions: Breast Neoplasms | Phase 2 | Status: UNKNOWN